649 results on '"Cullis, Pieter R."'
Search Results
2. siRNA-mediated reduction of a circulating protein in swine using lipid nanoparticles
3. Direct in vivo CAR T cell engineering
4. Determination of the interior pH of lipid nanoparticles using a pH-sensitive fluorescent dye-based DNA probe
5. Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer
6. Correction for Morozko et al., PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s disease
7. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s disease
8. Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues
9. Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective
10. Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
11. Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen
12. Development of a child-friendly oral drug formulation using liposomal multilamellar vesicle technology
13. Lipid nanoparticles to silence androgen receptor variants for prostate cancer therapy
14. Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNA
15. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles
16. Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A
17. Altering the intra-liver distribution of phospholipid-free small unilamellar vesicles using temperature-dependent size-tunability
18. The current landscape of nucleic acid therapeutics
19. Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency
20. Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor.
21. Single Pulse Nanosecond Laser‐Stimulated Targeted Delivery of Anti‐Cancer Drugs from Hybrid Lipid Nanoparticles Containing 5 nm Gold Nanoparticles
22. Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe In Situ Gene Editing in Human Skin
23. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use
24. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
25. Lipid Polymorphism
26. Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids
27. Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes
28. Drug Delivery Systems: Entering the Mainstream
29. Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency
30. Single pulse nanosecond laser‐stimulated targeted delivery of anti‐cancer drugs from hybrid lipid nanoparticles containing 5 nm gold nanoparticles
31. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA
32. Author Correction: The current landscape of nucleic acid therapeutics
33. Deep Phenotyping by Mass Cytometry and Single-Cell RNA-Sequencing Reveals LYN-Regulated Signaling Profiles Underlying Monocyte Subset Heterogeneity and Lifespan
34. Supplementary Table 1-2, Figures S1-4 from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer
35. Opportunities and challenges in mRNA-LNP vaccine design
36. Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles
37. Morphological Behavior of Liposomes and Lipid Nanoparticles
38. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
39. On the Influence of Nucleic Acid Backbone Modifications on Lipid Nanoparticle Morphology
40. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration
41. Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo
42. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System
43. Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective
44. Synthesis and Characterization of Hybrid Lipid Nanoparticles Containing Gold Nanoparticles and a Weak Base Drug
45. Exciting Times for Lipid Nanoparticles: How Canadian Discoveries Are Enabling Gene Therapies
46. Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA
47. Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA
48. Liposomal drug delivery systems: From concept to clinical applications
49. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System
50. Liposomal Vincristine: The Central Role of Drug Retention in Defining Therapeutically Optimized Anticancer Formulations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.